Trial
NCT00811915
Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University Hospital, Rouen
Collaborators
—
Condition
Kidney Transplantation
Intervention
Sirolimus
Why stopped
Difficulty in enrolling new patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-14